Cullinan Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.23M | Sell |
6,866
-112
| -2% | -$114K | 0.62% | 41 |
|
|
2026
Q1 | $6.42M | Sell |
6,978
-1,000
| -13% | -$1.01M | 0.52% | 52 |
|
|
2025
Q4 | $8.57M | Sell |
7,978
-965
| -11% | -$923K | 0.58% | 45 |
|
|
2025
Q3 | $6.82M | Buy |
8,943
+573
| +7% | +$426K | 0.44% | 52 |
|
|
2025
Q2 | $6.52M | Sell |
8,370
-1,000
| -11% | -$777K | 0.43% | 51 |
|
|
2025
Q1 | $7.74M | Buy |
9,370
+315
| +3% | +$262K | 0.55% | 45 |
|
|
2024
Q4 | $6.99M | Sell |
9,055
-311
| -3% | -$258K | 0.45% | 49 |
|
|
2024
Q3 | $8.5M | Buy |
9,366
+83
| +0.9% | +$74.6K | 0.48% | 49 |
|
|
2024
Q2 | $8.4M | Buy |
9,283
+2,655
| +40% | +$2.12M | 0.48% | 54 |
|
|
2024
Q1 | $5.16M | Buy |
6,628
+309
| +5% | +$220K | 0.29% | 74 |
|
|
2023
Q4 | $3.68M | Sell |
6,319
-1,054
| -14% | -$615K | 0.21% | 93 |
|
|
2023
Q3 | $3.96M | Buy |
7,373
+1,335
| +22% | +$688K | 0.23% | 92 |
|
|
2023
Q2 | $2.83M | Sell |
6,038
-100
| -2% | -$41.9K | 0.16% | 110 |
|
|
2023
Q1 | $2.11M | Sell |
6,138
-500
| -8% | -$169K | 0.12% | 119 |
|
|
2022
Q4 | $2.43M | Buy |
6,638
+2,438
| +58% | +$864K | 0.13% | 111 |
|
|
2022
Q3 | $1.36M | Buy |
4,200
+2,400
| +133% | +$760K | 0.09% | 130 |
|
|
2022
Q2 | $584K | Buy |
1,800
+600
| +50% | +$180K | 0.04% | 167 |
|
|
2022
Q1 | $344K | Hold |
1,200
| – | – | 0.02% | 197 |
|
|
2021
Q4 | $331K | Sell |
1,200
-500
| -29% | -$127K | 0.02% | 203 |
|
|
2021
Q3 | $393K | Sell |
1,700
-1,000
| -37% | -$247K | 0.02% | 191 |
|
|
2021
Q2 | $620K | Sell |
2,700
-176
| -6% | -$35.4K | 0.03% | 162 |
|
|
2021
Q1 | $537K | Sell |
2,876
-19,700
| -87% | -$3.85M | 0.03% | 153 |
|
|
2020
Q4 | $3.81M | Sell |
22,576
-49
| -0.2% | -$7.32K | 0.23% | 96 |
|
|
2020
Q3 | $3.35M | Sell |
22,625
-5,800
| -20% | -$898K | 0.22% | 97 |
|
|
2020
Q2 | $4.67M | Sell |
28,425
-2,500
| -8% | -$384K | 0.33% | 82 |
|
|
2020
Q1 | $4.29M | Sell |
30,925
-7,700
| -20% | -$1.06M | 0.35% | 76 |
|
|
2019
Q4 | $5.08M | Buy |
38,625
+1,700
| +5% | +$197K | 0.34% | 81 |
|
|
2019
Q3 | $4.13M | Sell |
36,925
-100
| -0.3% | -$11.1K | 0.29% | 84 |
|
|
2019
Q2 | $4.1M | Buy |
37,025
+100
| +0.3% | +$11.8K | 0.3% | 83 |
|
|
2019
Q1 | $4.79M | Sell |
36,925
-13,700
| -27% | -$1.67M | 0.36% | 77 |
|
|
2018
Q4 | $5.86M | Sell |
50,625
-2,642
| -5% | -$295K | 0.48% | 51 |
|
|
2018
Q3 | $5.72M | Buy |
53,267
+19,000
| +55% | +$1.9M | 0.41% | 72 |
|
|
2018
Q2 | $2.92M | Sell |
34,267
-500
| -1% | -$41.1K | 0.22% | 100 |
|
|
2018
Q1 | $2.69M | Buy |
34,767
+200
| +0.6% | +$16.1K | 0.2% | 104 |
|
|
2017
Q4 | $2.92M | Buy |
34,567
+1,300
| +4% | +$111K | 0.21% | 103 |
|
|
2017
Q3 | $2.85M | Buy |
33,267
+1,300
| +4% | +$107K | 0.22% | 106 |
|
|
2017
Q2 | $2.63M | Buy |
31,967
+200
| +0.6% | +$16.3K | 0.2% | 107 |
|
|
2017
Q1 | $2.67M | Buy |
31,767
+77
| +0.2% | +$6.17K | 0.22% | 106 |
|
|
2016
Q4 | $2.33M | Sell |
31,690
-677
| -2% | -$50.4K | 0.2% | 112 |
|
|
2016
Q3 | $2.6M | Buy |
32,367
+300
| +0.9% | +$24K | 0.22% | 105 |
|
|
2016
Q2 | $2.52M | Sell |
32,067
-300
| -0.9% | -$22.6K | 0.21% | 102 |
|
|
2016
Q1 | $2.33M | Buy |
32,367
+300
| +0.9% | +$22.7K | 0.2% | 102 |
|
|
2015
Q4 | $2.7M | Buy |
+32,067
| New | +$2.66M | 0.24% | 93 |
|
|
2015
Q3 | – | Sell |
-27,100
| Closed | -$2.26M | – | 215 |
|
|
2015
Q2 | $2.26M | Sell |
27,100
-4,000
| -13% | -$305K | 0.19% | 103 |
|
|
2015
Q1 | $2.26M | Sell |
31,100
-200
| -0.6% | -$14.2K | 0.18% | 108 |
|
|
2014
Q4 | $2.16M | Sell |
31,300
-1,900
| -6% | -$128K | 0.23% | 56 |
|
|
2014
Q3 | $2.15M | Sell |
33,200
-8,000
| -19% | -$507K | 0.25% | 55 |
|
|
2014
Q2 | $2.02M | Buy |
41,200
+7,300
| +22% | +$436K | 0.33% | 42 |
|
|
2014
Q1 | $2M | Buy |
33,900
+3,700
| +12% | +$206K | 0.23% | 57 |
|
|
2013
Q4 | $1.54M | Sell |
30,200
-9,800
| -25% | -$491K | 0.18% | 60 |
|
|
2013
Q3 | $2.01M | Sell |
40,000
-33,288
| -45% | -$1.74M | 0.27% | 53 |
|
|
2013
Q2 | $3.6M | Buy |
+73,288
| New | +$3.99M | 0.49% | 36 |
|
Other funds holding LLY
Cullinan Associates's LLY Position: Q2 2026 in Review
Cullinan Associates reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $114K and leaving 6,866 shares worth $8.23M. The position accounts for 0.62% of the portfolio, ranked #41.
Cullinan Associates first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.57M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cullinan Associates held 6,866 shares of Eli Lilly worth $8.23M as of Q2 2026.
- Cullinan Associates sold 112 Eli Lilly shares in Q2 2026, an estimated $114K.
- Eli Lilly made up 0.62% of Cullinan Associates's portfolio in Q2 2026, its #41 holding.
- Cullinan Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Cullinan Associates's Eli Lilly position peaked at $8.57M in Q4 2025.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.